Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
RecruitingNCT03603730Phase: NAStarted 2018-11-30
Summary
Explore the effects of auricular transcutaneous vagal nerve stimulation (taVNS) on brain and stomach outcomes in functional dyspepsia and gastroparesis patients.
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
70 Years
Locations
Massachusetts General HospitalBoston, Massachusetts, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT03603730